Procalcitonin as an Indicator of Infection in Patients with Liver Cirrhosis;Prokalcitonin jako Indikátor Infekce u Pacientů s Jaterní Cirhózou

Vnitrni Lekarstvi

Volumn 50, Issue 2, 2004, Pages 153-156

  Husová, Libuše ^a   Husa, P ^a   Senkyrik M ^a   Lata, J ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Bacterial infection; Liver cirrhosis; Procalcitonin

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3A; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL PERITONITIS; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; ERYTHROCYTE SEDIMENTATION RATE; HALF LIFE TIME; HOSPITAL INFECTION; HOSPITALIZATION; INCIDENCE; INFLAMMATION; LABORATORY TEST; LEUKOCYTE COUNT; LIVER CIRRHOSIS; LIVER DYSFUNCTION; MONITORING; MYCOSIS; PARASITOSIS; PROGNOSIS; RESPIRATORY TRACT INFECTION; THYROID GLAND; URINARY TRACT INFECTION;

BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CALCITONIN; DIAGNOSIS, DIFFERENTIAL; HUMANS; LIVER CIRRHOSIS; PROTEIN PRECURSORS;

EID: 1442315484     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Bernard, B., Grande, J. D., Khac, E. N. et al.: Antibiotic profylaxis for the prevention of bacterial infection in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology, 29, 1999, 6, 1655-1661
2. Burroughs, A. K.: General management of the cirrhotic patient with acute variceal bleeding. In: De Franchis, R.: Portal hypertension III, proceedings of the third Baveno international consensus worshop on definitions, methodology and therapeutic strategies, Blackwell Science Ltd., Oxford, 2001, 1. vydání, 135-142
3. Burroughs, A., Dagher, L.: Treatment strategies for acute variceal bleeding, clinical management of portal hypertension and its complications. Postgraduate course. EASL, Prague, Czech republic, April 19, 2001, 38-57
4. Campillo, B.: Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotics pacients. Clin. Infect. Dis., 35, 2002, 1, 1-10
5. Deschenes, M., Villeneuve, J. P.: Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis. Am. J. Gastroenterol., 94, 1999, 8, 2193-2197
6. Fernández, J., Navasa, M., Gómez, J. et al.: Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin profylaxis. Hepatology, 35, 2002, 1, 140-148
7. Ferriere, F.: Procalcitonin, a new marker for bacterial infections. Ann. Biol. Clin., 58, 2000, 1, 49-59
8. th Interscience conference on antimicrobial agents and chemotherapy, San Diego, Cakifornia, September 24-27, 1998, D 108
9. Goulis, J., Armonis, A., Patch, D. et al.: Bacterial infection is independently associated with failure control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology, 27, 1998, 5, 1207-1212
10. Kienslichová, E.: Sepse u nemocných s jaterním selhánim, Bulletin HPB, 10, 2002, 2-3, 63-66.
11. Liberati, A., D'Amico, R., Pifferi, S. et al.: Antibiotic prophylaxis in intensive care units: meta-analyses versus clinical practice. Intensive Care Med., 26, 2000, 1, 38-44
12. Meisner, M.: PCT, Procalcitonin-a new, innovative infection parameter, 1996, Berlin, Brahams-diagnostica, 80 s.
13. Meisner, M.: Procalcitonin (PCT) - a new, innovative infection parameter. Biochemical and clinical aspects, 2000, 3. Vydání, Sttutgart, New York, Thieme, 195 s.
14. Meisner, M., Brukhorst, F. M., Reith, H. B. et al.: Clinical experiences with a new semi-quantitative solid phase immunoassay for rapid measurement of procaltocin. Clin. Chem. Lab., 38, 2000, 10, 989-995
15. Montalto, P., Vlachogiannakos, J., Cox, D., J. et al.: Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. Journal of hepatology, 37, 2002, 4, 463-470
16. Navasa, M., Fermández, J., Rodés, J.: Prophylaxis of spontaneous bacterial peritonitis. The problem of spontanous bacterial peritonitis by quinolone-resistant bacteria. In: Arroyo, V., Bosch, J., Bruix, J. et al.: Therapy in hepatology. Barcelona, Ars Medica 2001, 65-71
17. Pratt, D. S., Epstein, S. K.: Recent advances in critical care gastroenterology. Am. J. Respir. Crit. Med., 161, 2000, 1417-1420
18. Stoutembeek, C. P., Van Saene, H. K. F., Miranda, D. et al.: The effect of selective decontamination of the digestive tract on colonization and infection rate in multiple trauma patients. Intensive Care Med.,10, 1984, 185-192
19. Teres, D., Rapoport, J., Lemeshow, S. et al.: Effects of severity of illness on resource use by survivors and non survivors of severe sepsis at intensive care unit admission. Crit. Care Med., 30, 2002, 11, 2413-2419
20. Thulstrup, A. M.: Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis. Clin. Infect. Dis., 31, 2000, 6, 1357-1361
21. Viallon, A., Zeni, F., Pouzet, V. et al.: Serum and ascitic procalcitonin levels in cirrhotics patients with spontaneous bacterial peritonitis: diagnostic value and relationship to pro-inflammatory cytokines. Intensice care Med., 26, 2000, 8, 1082-1088
22. Průcha, M., Zazula, R., Hyánek, J.: Prokalcitonin - senzitivní a specifický parametr těžkého bakteriálního zánětu. Anesteziologie a neodkladná péče, 13, 2002, 2, 83-85
23. Zazula, R., Průcha, M., Spálený, A. et al.: Prokalcitonin nejen v diferenciální zánětlivé odpovědi organismu. Anesteziologie a neodkladná péče, 13, 2002, 2, 86-91